bf/NASDAQ:INM_icon.png

NASDAQ:INM

InMed Pharmaceuticals Inc.

  • Stock

USD

Last Close

1.71

06/11 22:18

Market Cap

2.35M

Beta: 1.06

Volume Today

42.41K

Avg: 631.00K

PE Ratio

−0.16

PFCF: −0.24

OverviewFinancialsAPI

    Description

    InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment ...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -300-200-1002019-05-152020-12-172022-02-142023-06-292024-10-04

    Revenue (Estimate*)

    200M400M600M800M2019-05-152020-12-172022-02-142023-06-292024-10-04

    *Estimate based on analyst consensus